Sensei Biotherapeutics, Inc. · NASDAQ:SNSE
Montanova Capital, LLC reported a 7.80% stake in Sensei Biotherapeutics, Inc. (Schedule 13G)
Event Jun 15, 2026 · Filed Jun 23, 2026
Montanova Capital, LLC reported a 7.80% stake in Sensei Biotherapeutics, Inc., 2,020,103 shares, as a passive investor on Jun 15, 2026. Filed Jun 23, 2026 (Schedule 13G).
- Stake
- 7.80%
- Shares
- 2,020,103
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Suvretta Capital Management, LLC | 7.80% | 2,020,103 |
| Averill Master Fund, Ltd. | 6.70% | 1,722,652 |
| Aaron Cowen | 7.80% | 2,020,103 |
Source
Related
- Sensei Biotherapeutics, Inc.
- Montanova Capital, LLC
- Sensei Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Stempoint Capital LP · Aug 14, 2026
- Schedule 13G · VK Services, LLC · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026
- Schedule 13G · S2G Investments, LLC · Jun 23, 2026